InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,584.54
(
-0.88%
)
US TECH 100
19,681.20
(
-2.17%
)
Dow Jones
39,753.75
(
0.08%
)
Brent Oil
85.26
(
0.17%
)
Bitcoin
57,299.81
(
-0.09%
)
Post# of 252581
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

AlpineBV_Miller

Send PM Follow Ignore
Followers 56
Posts 1150
Boards Moderated 0
Alias Born 11/12/2005

AlpineBV_Miller

Re: rkrw post# 90088

Wednesday, 02/03/2010 4:48:57 PM

Wednesday, February 03, 2010 4:48:57 PM

Post# of 252581
There's lots that can go wrong with any drug launch. The wreckage is considerable for dev-stage biotechs trying to transition into operating companies (really ANY company trying to make that transition). I just don't happen to believe manufacturing problems will be an issue for Provenge.

Unless otherwise indicated, this is the personal viewpoint of David Miller and not necessarily that of Biotech Stock Research, LLC. We're on Twitter at BiotechStockRsr.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up